These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 17208328)
21. The relationship of metalloproteinase gene polymorphisms and lung cancer. Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389 [TBL] [Abstract][Full Text] [Related]
23. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834 [TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer. Heist RS; Marshall AL; Liu G; Zhou W; Su L; Neuberg D; Lynch TJ; Wain J; Christiani DC Clin Cancer Res; 2006 Sep; 12(18):5448-53. PubMed ID: 17000679 [TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer. Lin TS; Huang HH; Fan YH; Chiou SH; Chow KC Oncol Rep; 2007 Mar; 17(3):565-72. PubMed ID: 17273734 [TBL] [Abstract][Full Text] [Related]
26. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer. Li L; Mei TH; Zhou XD; Zhang XG Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419 [TBL] [Abstract][Full Text] [Related]
27. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. Lin SC; Lo SS; Liu CJ; Chung MY; Huang JW; Chang KW J Oral Pathol Med; 2004 Aug; 33(7):405-9. PubMed ID: 15250832 [TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818 [TBL] [Abstract][Full Text] [Related]
29. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. Okamoto K; Mimura K; Murawaki Y; Yuasa I J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221 [TBL] [Abstract][Full Text] [Related]
30. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Hao B; Miao X; Li Y; Zhang X; Sun T; Liang G; Zhao Y; Zhou Y; Wang H; Chen X; Zhang L; Tan W; Wei Q; Lin D; He F Oncogene; 2006 Jun; 25(25):3613-20. PubMed ID: 16652158 [TBL] [Abstract][Full Text] [Related]
31. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657 [TBL] [Abstract][Full Text] [Related]
32. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721 [TBL] [Abstract][Full Text] [Related]
33. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826 [TBL] [Abstract][Full Text] [Related]
34. Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer. Safranek J; Holubec L; Topolcan O; Pesta M; Klecka J; Vodicka J; Finek J; Kormunda S; Pesek M Anticancer Res; 2007; 27(4C):2953-6. PubMed ID: 17695477 [TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174 [TBL] [Abstract][Full Text] [Related]
36. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer]. Lou Y; Fang CQ; Li JH Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546 [TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Su L; Zhou W; Park S; Wain JC; Lynch TJ; Liu G; Christiani DC Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330 [TBL] [Abstract][Full Text] [Related]
38. [Polymorphism of gene promotor region for MMP-2 in rheumatoid arthritis]. Nemec P; Goldbergová M; Swobodnik T; Polásková D; Soucek M; Vasků A Vnitr Lek; 2006 Apr; 52(4):348-54. PubMed ID: 16755991 [TBL] [Abstract][Full Text] [Related]
39. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis. de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353 [TBL] [Abstract][Full Text] [Related]
40. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Yu C; Pan K; Xing D; Liang G; Tan W; Zhang L; Lin D Cancer Res; 2002 Nov; 62(22):6430-3. PubMed ID: 12438229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]